Wale Atoyebi

1.1k total citations
15 papers, 557 citations indexed

About

Wale Atoyebi is a scholar working on Hematology, Genetics and Genetics. According to data from OpenAlex, Wale Atoyebi has authored 15 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 8 papers in Genetics and 3 papers in Genetics. Recurrent topics in Wale Atoyebi's work include Hemoglobinopathies and Related Disorders (7 papers), Iron Metabolism and Disorders (5 papers) and Blood groups and transfusion (4 papers). Wale Atoyebi is often cited by papers focused on Hemoglobinopathies and Related Disorders (7 papers), Iron Metabolism and Disorders (5 papers) and Blood groups and transfusion (4 papers). Wale Atoyebi collaborates with scholars based in United Kingdom, United States and Nigeria. Wale Atoyebi's co-authors include Baba Inusa, Lewis L. Hsu, Kofi A. Anie, Neeraj Kohli, S. M. BURRIDGE, K. POWELL, C. Brown, G. D. Bell, Philip H. Jones and Chris Frost and has published in prestigious journals such as The Lancet, British Journal of Haematology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Wale Atoyebi

15 papers receiving 540 citations

Peers

Wale Atoyebi
D. W. Dawson United Kingdom
Ahti Lammi Australia
H Jackson United Kingdom
C. van Deursen Netherlands
O’Neill Barrett United States
Jesús Acosta Ortega United States
D. W. Dawson United Kingdom
Wale Atoyebi
Citations per year, relative to Wale Atoyebi Wale Atoyebi (= 1×) peers D. W. Dawson

Countries citing papers authored by Wale Atoyebi

Since Specialization
Citations

This map shows the geographic impact of Wale Atoyebi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wale Atoyebi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wale Atoyebi more than expected).

Fields of papers citing papers by Wale Atoyebi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wale Atoyebi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wale Atoyebi. The network helps show where Wale Atoyebi may publish in the future.

Co-authorship network of co-authors of Wale Atoyebi

This figure shows the co-authorship network connecting the top 25 collaborators of Wale Atoyebi. A scholar is included among the top collaborators of Wale Atoyebi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wale Atoyebi. Wale Atoyebi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Inusa, Baba, et al.. (2023). Global burden of transfusion in sickle cell disease. Transfusion and Apheresis Science. 62(5). 103764–103764. 6 indexed citations
2.
Inusa, Baba, Claire Stewart, Jerlym S. Porter, et al.. (2020). Paediatric to adult transition care for patients with sickle cell disease: a global perspective. The Lancet Haematology. 7(4). e329–e341. 27 indexed citations
3.
Telfer, Paul, Perla Eleftheriou, Josu de la Fuente, et al.. (2020). Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID‐19 pandemic. British Journal of Haematology. 189(4). 635–639. 37 indexed citations
4.
Inusa, Baba, et al.. (2019). Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment. International Journal of Neonatal Screening. 5(2). 20–20. 127 indexed citations
6.
Atoyebi, Wale, et al.. (2016). Update on sickle cell disease. British Journal of Hospital Medicine. 77(4). C55–C59. 4 indexed citations
7.
Roy, Noémi, Saul Myerson, Anna Schuh, et al.. (2011). Cardiac iron overload in transfusion‐dependent patients with myelodysplastic syndromes. British Journal of Haematology. 154(4). 521–524. 48 indexed citations
8.
Medd, Patrick, Susan H. Turner, Graham P. Collins, et al.. (2011). A novel scoring system combining expression of CD23, CD20, and CD38 with platelet count predicts for the presence of the t(11;14) translocation of mantle cell lymphoma. Cytometry Part B Clinical Cytometry. 80B(4). 230–237. 12 indexed citations
9.
Hin, Harold, Robert Clarke, Paul Sherliker, et al.. (2006). Clinical relevance of low serum vitamin B12 concentrations in older people: the Banbury B12 study. Age and Ageing. 35(4). 416–422. 124 indexed citations
10.
Atoyebi, Wale, Matthew A. Brown, John Wass, Timothy J. Littlewood, & Chris Hatton. (2002). Lymphoplasmacytoid lymphoma presenting as severe osteoporosis. American Journal of Hematology. 70(1). 77–80. 2 indexed citations
11.
Atoyebi, Wale, et al.. (2002). Treatment of myelodysplasia with oral cyclosporin. Clinical & Laboratory Haematology. 24(4). 211–214. 12 indexed citations
12.
Atoyebi, Wale, et al.. (2000). Is it necessary to administer anti‐D to prevent RhD immunization after the transfusion of RhD‐positive platelet concentrates?. British Journal of Haematology. 111(3). 980–983. 32 indexed citations
13.
Atoyebi, Wale, et al.. (2000). Is it necessary to administer anti-D to prevent RhD immunization after the transfusion of RhD-positive platelet concentrates?. British Journal of Haematology. 111(3). 980–983. 9 indexed citations
14.
Atoyebi, Wale, et al.. (1997). Glutathione S-transferase theta 1 (GSTT1) gene defect in myelodysplasia and acute myeloid leukaemia. The Lancet. 349. 1450–1451. 1 indexed citations
15.
Bell, G. D., K. POWELL, S. M. BURRIDGE, et al.. (1995). Rapid eradication of Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics. 9(1). 41–46. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026